BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Treatment
30 results:

  • 1. pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.
    Dutta D; Ray P; De A; Ghosh A; Hazra RS; Ghosh P; Banerjee S; Diaz FJ; Upadhyay SP; Quadir M; Banerjee SK
    PLoS One; 2024; 19(4):e0297749. PubMed ID: 38687749
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer.
    Prajapati DR; Molczyk C; Purohit A; Saxena S; Sturgeon R; Dave BJ; Kumar S; Batra SK; Singh RK
    Cancer Lett; 2023 Jun; 563():216185. PubMed ID: 37062329
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Safety and management of niraparib monotherapy in ovarian cancer clinical trials.
    Monk BJ; González-Martin A; Buckley L; Matulonis UA; Rimel BJ; Wu X; Moore KN; Mirza MR
    Int J Gynecol Cancer; 2023 Jun; 33(6):971-981. PubMed ID: 36792166
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Survival after hemithyroidectomy versus total thyroidectomy in non-high-risk differentiated thyroid cancer: population-based analysis.
    Liu X; Wong CKH; Chan WWL; Au ICH; Tang EHM; Lang BHH
    BJS Open; 2022 Nov; 6(6):. PubMed ID: 36426588
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Approach to the Patient With a Suppressed TSH.
    Praw SS; Brent GA
    J Clin Endocrinol Metab; 2023 Jan; 108(2):472-482. PubMed ID: 36329632
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Potential utility of cone-beam CT-guided adaptive radiotherapy under end-exhalation breath-hold conditions for pancreatic cancer.
    Ogawa A; Nakamura M; Iramina H; Yoshimura M; Mizowaki T
    J Appl Clin Med Phys; 2023 Feb; 24(2):e13827. PubMed ID: 36316795
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic cancer AsPC-1 and MIAPaCa-2 Cell Lines.
    Takikawa T; Hamada S; Matsumoto R; Tanaka Y; Kataoka F; Sasaki A; Masamune A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012531
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combined inhibition of IL‑6 and IL‑8 pathways suppresses ovarian cancer cell viability and migration and tumor growth.
    Zhang R; Roque DM; Reader J; Lin J
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35315502
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Postpartum Levothyroxine Adjustment and Its Impact Factors in Women With Hypothyroidism in Pregnancy.
    Gao X; Liu A; Wang X; Han Y; Wang H; Li J; Hou Y; Yang Y; Wang H; Zhang C; Teng W; Shan Z
    Endocr Pract; 2022 Jun; 28(6):578-585. PubMed ID: 35278704
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Skull Base Tumors: Neuropathology and Clinical Implications.
    Bi WL; Santagata S
    Neurosurgery; 2022 Mar; 90(3):243-261. PubMed ID: 34164689
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Radiation-Induced Autophagy in Human Pancreatic cancer Cells is Critically Dependent on G2 Checkpoint Activation: A Mechanism of Radioresistance in Pancreatic cancer.
    Suzuki M; Anko M; Ohara M; Matsumoto KI; Hasegawa S
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):260-271. PubMed ID: 34112559
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast cancer or Ovarian cancer, 2012-2019.
    Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
    J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities.
    Cheasley D; Nigam A; Zethoven M; Hunter S; Etemadmoghadam D; Semple T; Allan P; Carey MS; Fernandez ML; Dawson A; Köbel M; Huntsman DG; Le Page C; Mes-Masson AM; Provencher D; Hacker N; Gao Y; Bowtell D; deFazio A; Gorringe KL; Campbell IG
    J Pathol; 2021 Jan; 253(1):41-54. PubMed ID: 32901952
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma.
    Gülsoy Kirnap N; Turhan Iyidir Ö; Bozkuş Y; Işildak ŞM; Anil C; Firat SN; Demir C; Nar A; Başçil Tütüncü N
    Turk J Med Sci; 2020 Jun; 50(4):870-876. PubMed ID: 32490648
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of Mean Platelet Volume, Platelet Count, Neutrophil/ Lymphocyte Ratio and Platelet/Lymphocyte Ratio in the Euthyroid, Overt Hypothyroid and Subclinical Hyperthyroid Phases of Papillary Thyroid Carcinoma.
    Kutluturk F; Gul SS; Sahin S; Tasliyurt T
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):859-865. PubMed ID: 30727930
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Evaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitary.
    Soukup J; Kasparova P; Kohout A; Rychly B; Skarkova V; Syrucek M; Gabalec F
    Pituitary; 2019 Feb; 22(1):70-78. PubMed ID: 30607746
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Evaluation of thyroid nodule characteristics in subclinical hypothyroid patients under a myo-inositol plus selenium treatment.
    Nordio M; Basciani S
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2153-2159. PubMed ID: 29687875
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
    Vigário Pdos S; Chachamovitz DS; Teixeira Pde F; Rocque Mde L; Santos ML; Vaisman M
    Arq Bras Endocrinol Metabol; 2014 Apr; 58(3):274-81. PubMed ID: 24863090
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Analyses of merlin/nf2 connection to FAK inhibitor responsiveness in serous ovarian cancer.
    Shah NR; Tancioni I; Ward KK; Lawson C; Chen XL; Jean C; Sulzmaier FJ; Uryu S; Miller NL; Connolly DC; Schlaepfer DD
    Gynecol Oncol; 2014 Jul; 134(1):104-11. PubMed ID: 24786638
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The expression and phosphorylation of ezrin and merlin in human pancreatic cancer.
    Zhou J; Feng Y; Tao K; Su Z; Yu X; Zheng J; Zhang L; Yang D
    Int J Oncol; 2014 Jun; 44(6):2059-67. PubMed ID: 24728215
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.